Cover Image
市場調查報告書

動脈瘤:全球臨床實驗趨勢

Aneurysm Global Clinical Trials Review, H1, 2015

出版商 GlobalData 商品編碼 237444
出版日期 內容資訊 英文 91 Pages
訂單完成後即時交付
價格
Back to Top
動脈瘤:全球臨床實驗趨勢 Aneurysm Global Clinical Trials Review, H1, 2015
出版日期: 2015年03月31日 內容資訊: 英文 91 Pages
簡介

本報告提供動脈瘤的臨床實驗相關基本資料和數據,提供您各地區,各階段,各進展狀況的實施數量,代表性贊助商,開發中的治療藥資訊,全球各國的主要企業·機關的臨床試驗進展,有潛力的藥劑比較等資訊。

簡介

  • 動脈瘤
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主要國家的臨床實驗數量
    • 歐洲主要5國的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中東·非洲主要國家的臨床實驗數量
    • 中南美主要國家的臨床實驗數量

G7各國臨床實驗數量:心血管系統治療藥臨床實驗上動脈瘤的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:心血管系統治療藥臨床實驗上動脈瘤的比例

E7各國的各階段臨床實驗數量

E7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

未完成的臨床實驗數量

一定期間所採用的實驗對象

贊助商類別的臨床實驗數量

有潛力的贊助商

動脈瘤治療藥臨床實驗的主要參與企業

有潛力的藥劑

臨床實驗簡介

  • 主要企業臨床實驗概要
    • Novartis AG
    • NoNO, Inc.
    • Sanofi
    • Johnson & Johnson
    • Hope Pharmaceuticals, Inc.
    • Fresenius Kabi AG
    • Edge Therapeutics, Inc.
  • 有代表性的研究機關·醫院臨床實驗概要
    • Leiden University Medical Center
    • Assistance Publique - Hopitaux de Paris
    • 日本大學
    • Tohoku University School of Medicine
    • Academic Medical Center
    • Centre Hospitalier Universitaire de Nice
    • Duke University
    • Hospital Israelita Albert Einstein
    • Imperial College London
    • James Cook University

5個有代表性的臨床實驗簡介

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC2610CTIDB

GlobalData's clinical trial report, "Aneurysm Global Clinical Trials Review, H1, 2015" provides data on the Aneurysm clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Aneurysm. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Aneurysm. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Aneurysm
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Aneurysm to Cardiovascular Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Aneurysm to Cardiovascular Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Aneurysm
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Aneurysm Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
      • NoNO, Inc.
      • Clinical Trial Overview of NoNO, Inc.
      • Sanofi
      • Clinical Trial Overview of Sanofi
      • Johnson & Johnson
      • Clinical Trial Overview of Johnson & Johnson
      • Hope Pharmaceuticals, Inc.
      • Clinical Trial Overview of Hope Pharmaceuticals, Inc.
      • Fresenius Kabi AG
      • Clinical Trial Overview of Fresenius Kabi AG
      • Edge Therapeutics, Inc.
      • Clinical Trial Overview of Edge Therapeutics, Inc.
    • Clinical Trial Overview of Top Institutes / Government
      • Leiden University Medical Center
      • Clinical Trial Overview of Leiden University Medical Center
      • Assistance Publique - Hopitaux de Paris
      • Clinical Trial Overview of Assistance Publique - Hopitaux de Paris
      • Nihon University
      • Clinical Trial Overview of Nihon University
      • Tohoku University School of Medicine
      • Clinical Trial Overview of Tohoku University School of Medicine
      • Academic Medical Center
      • Clinical Trial Overview of Academic Medical Center
      • Centre Hospitalier Universitaire de Nice
      • Clinical Trial Overview of Centre Hospitalier Universitaire de Nice
      • Duke University
      • Clinical Trial Overview of Duke University
      • Hospital Israelita Albert Einstein
      • Clinical Trial Overview of Hospital Israelita Albert Einstein
      • Imperial College London
      • Clinical Trial Overview of Imperial College London
      • James Cook University
      • Clinical Trial Overview of James Cook University
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Aneurysm Therapeutics, Global, Clinical Trials by Region, 2015*
  • Aneurysm Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Aneurysm Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Aneurysm Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015*
  • Aneurysm Therapeutics Clinical Trials, Europe, Top Five Countries, 2015*
  • Aneurysm Therapeutics Clinical Trials, North America, Top Countries, 2015*
  • Aneurysm Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015*
  • Aneurysm Therapeutics Clinical Trials, Central and South America, Top Countries, 2015*
  • Proportion of Aneurysm to Cardiovascular Clinical Trials, G7 Countries (%), 2015*
  • Aneurysm Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Aneurysm Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Aneurysm to Cardiovascular Clinical Trials, E7 Countries (%), 2015*
  • Aneurysm Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Aneurysm Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Aneurysm Therapeutics, Global, Clinical Trials by Phase, 2015*
  • Aneurysm Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
  • Aneurysm Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Aneurysm Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Aneurysm Therapeutics, Global, Suspended Clinical Trials, 2015*
  • Aneurysm Therapeutics, Global, Withdrawn Clinical Trials, 2015*
  • Aneurysm Therapeutics, Global, Terminated Clinical Trials, 2015*
  • Aneurysm Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Aneurysm Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
  • Aneurysm Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Aneurysm Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Aneurysm Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • Aneurysm Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015*
  • Aneurysm Therapeutics Clinical Trials Market, Global, Clinical Trials by NoNO, Inc., 2015*
  • Aneurysm Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2015*
  • Aneurysm Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2015*
  • Aneurysm Therapeutics Clinical Trials Market, Global, Clinical Trials by Hope Pharmaceuticals, Inc., 2015*
  • Aneurysm Therapeutics Clinical Trials Market, Global, Clinical Trials by Fresenius Kabi AG, 2015*
  • Aneurysm Therapeutics Clinical Trials Market, Global, Clinical Trials by Edge Therapeutics, Inc., 2015*
  • Aneurysm Therapeutics Clinical Trials Market, Global, Clinical Trials by Leiden University Medical Center, 2015*
  • Aneurysm Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2015*
  • Aneurysm Therapeutics Clinical Trials Market, Global, Clinical Trials by Nihon University, 2015*
  • Aneurysm Therapeutics Clinical Trials Market, Global, Clinical Trials by Tohoku University School of Medicine, 2015*
  • Aneurysm Therapeutics Clinical Trials Market, Global, Clinical Trials by Academic Medical Center, 2015*
  • Aneurysm Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre Hospitalier Universitaire de Nice, 2015*
  • Aneurysm Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2015*
  • Aneurysm Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospital Israelita Albert Einstein, 2015*
  • Aneurysm Therapeutics Clinical Trials Market, Global, Clinical Trials by Imperial College London, 2015*
  • Aneurysm Therapeutics Clinical Trials Market, Global, Clinical Trials by James Cook University, 2015*

List of Figures

  • Aneurysm Therapeutics, Global, Clinical Trials by Region (%), 2015*
  • Aneurysm Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Aneurysm Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Aneurysm Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015*
  • Aneurysm Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015*
  • Aneurysm Therapeutics Clinical Trials, North America, Top Countries (%), 2015*
  • Aneurysm Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015*
  • Proportion of Aneurysm to Cardiovascular Clinical Trials, G7 Countries (%), 2015*
  • Aneurysm Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Aneurysm Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Aneurysm to Cardiovascular Clinical Trials, E7 Countries (%), 2015*
  • Aneurysm Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Aneurysm Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Aneurysm Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Aneurysm Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
  • Aneurysm Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Aneurysm Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Aneurysm Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Aneurysm Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
  • Aneurysm Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Aneurysm Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Aneurysm Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • GlobalData Methodology
Back to Top